CompoAtlas

Serra Plus

Serra Plus, licence 80145654: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Infla Ease, Serra Max, Serra Max Forte, Serra Plus Forte
Licence holder
Provita Nutrition and Health Inc.
NPN or DIN-HM
80145654
Status
Active licence
Licence date
26 November 2025
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine

Source : Piper nigrum - fruit

5.0 mgNot calculated
Serratiopeptidase

Source : Serratia marcescens E-15 - Cellule Entiière

50.0 mgNot calculated
Bromélaïne de tige

Source : Ananas comosus var. comosus - Tige

3000000.0 Unités de papaïne du FCCNot calculated
Papaïne

Source : Carica papaya - fruit

300000.0 Unités de papaïne du FCCNot calculated
Boswellia serrata

Source : Boswellia serrata - Oléo-gomme-résine (écorce de tige)

Extract : Matériel brut sec

Extraction ratio : 15-18:1

Dry plant equivalent : 1500-1800 mg

Potency : 65.0 % Boswellic acids

100.0 mgNot calculated
Zingiber officinale

Source : Zingiber officinale - Rhizome

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 500 mg

50.0 mgNot calculated
Curcuma longa

Source : Curcuma longa - rhizome

Potency : 95.0 % Curcuminoids

50.0 mgNot calculated
Tétrahydrocurcuminoïdes

Source : Tétrahydrocurcuminoïdes

50.0 mgNot calculated
Serratiopeptidase

Source : Serratia marcescens E-15 - Cellule Entiière

120000.0 SPUNot calculated

Non-medicinal ingredients

Gomme de gellane, Stéaryl fumarate de sodium, Cellulose microcristalline, Hydroxypropylméthylcellulose, Palmitate d'ascorbyle, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18.0 Année(s)1.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous. Proteolytic enzyme. Used in Herbal Medicine to help relieve minor pain, swelling and inflammation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80145654

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line